SOLIGENIX, INC. — Director's Dealing 2007

Aug 22, 2007

SEC Form 4/A — Form 4/A

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2007-08-10

Reporting Person: KUO JAMES S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-10	Stock Option (Right to Buy)	$0.47	A	350000	Acquired	2017-08-09	Common Stock (350000)	Direct

Footnotes

F1: Stock Options granted to Dr. Kuo for becoming the Company's Chairman of the Board of Directors. The stock options were granted at an exercise price of $0.47 per share, which is a 68% premium to the Company?s common stock price of $0.28 on August 10, 2007. The term of the stock options are 10 years. This Form amends the previously filed form on August 14, 2007 to correct the vesting schedule to the stock options, from vesting 25% immediately and 25% every year for 3 years to vesting all the stock options immediately.